tiprankstipranks
Trending News
More News >
Terumo (JP:4543)
:4543
Japanese Market
Advertisement

Terumo (4543) Earnings Dates, Call Summary & Reports

Compare
5 Followers

Earnings Data

Report Date
Feb 05, 2026
TBA (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
23.58
Last Year’s EPS
23.96
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Nov 12, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue and profit growth, successful product launches, and a positive impact from strategic acquisitions. However, challenges such as tariff impacts, temporary costs, and lower than expected demand in certain areas balanced the overall outlook.
Company Guidance
In the financial call for the second quarter of the fiscal year ending March 2026, Terumo Inc. announced record-high revenue of JPY 534.9 billion, despite an 8% decrease in revenue on a local currency basis, primarily due to strong demand in North America. Operating profit and adjusted operating profit also reached record highs of JPY 1.0 billion and JPY 114.4 billion, respectively. The company revised its full-year guidance upward, reflecting strong business fundamentals and favorable foreign exchange impacts from yen depreciation. However, these gains were offset by temporary costs related to strategic initiatives, including acquisition-related expenses and portfolio reviews. The Cardiac and Vascular Company reported an 8% revenue growth in local currency, while TMCS Medical Care Solutions saw increased revenue driven by Pharmaceuticals, despite some supply issues. The Blood and Cell Technologies division experienced significant revenue growth, particularly in Plasma Innovation and Global Blood Solutions. Terumo also highlighted the strategic introduction of the Dual Sensor System in the Imaging segment, expected to drive significant growth, and provided updates on the OrganOx acquisition, projecting substantial future revenue growth.
Record High Revenue for First Half
Revenue for the first half reached a record high of JPY 534.9 billion, driven by strong demand in North America, although there was an 8% decrease in revenue on a local currency basis.
Profit Growth Exceeds Revenue Growth
Operating profit, adjusted operating profit, and profit for the period all reached record highs for the first half. Profit growth was driven by global pricing measures and appropriate cost control.
Upward Revision of Full Year Guidance
Full year guidance was revised upward for revenue and adjusted operating profit, reflecting strong fundamentals and changes in foreign exchange assumptions due to yen depreciation.
Successful Launch of Dual Sensor System (DSS)
Terumo developed the Dual Sensor System featuring both IVUS and OFDI sensors, allowing simultaneous acquisition of two images. This innovation is expected to drive significant growth in the imaging market.
High Growth Potential for OrganOx Acquisition
OrganOx acquisition completed, with revenue expected to reach $120 million for calendar year 2025, representing approximately 70% growth over last year. The company aims for a revenue scale of JPY 100 billion over the next 10 years.

Terumo (JP:4543) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

JP:4543 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 05, 2026
2026 (Q3)
23.58 / -
23.96
Nov 12, 2025
2026 (Q2)
24.50 / 23.76
19.7520.30% (+4.01)
Aug 07, 2025
2026 (Q1)
24.40 / 28.37
22.8224.32% (+5.55)
May 14, 2025
2025 (Q4)
20.75 / 12.48
17.82-29.97% (-5.34)
Feb 13, 2025
2025 (Q3)
25.63 / 23.96
20.0319.62% (+3.93)
Nov 07, 2024
2025 (Q2)
22.12 / 19.75
18.4956.79% (+1.25)
Aug 08, 2024
2025 (Q1)
20.89 / 22.82
15.1450.73% (+7.68)
May 14, 2024
2024 (Q4)
18.61 / 17.82
12.87538.41% (+4.95)
Feb 07, 2024
2024 (Q3)
19.77 / 20.03
19.940.45% (+0.09)
Nov 14, 2023
2024 (Q2)
15.82 / 18.50
11.8855.68% (+6.62)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

JP:4543 Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
¥2518.50¥2544.50+1.03%
Aug 07, 2025
¥2545.30¥2514.49-1.21%
May 14, 2025
¥2767.43¥2709.79-2.08%
Feb 13, 2025
¥2762.65¥2810.14+1.72%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Terumo (JP:4543) report earnings?
Terumo (JP:4543) is schdueled to report earning on Feb 05, 2026, TBA (Confirmed).
    What is Terumo (JP:4543) earnings time?
    Terumo (JP:4543) earnings time is at Feb 05, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Terumo stock?
          The P/E ratio of Terumo is N/A.
            What is JP:4543 EPS forecast?
            JP:4543 EPS forecast for the fiscal quarter 2026 (Q3) is 23.58.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis